Key facts
- It has raised $13.7M; the latest was Later Stage VC ($13.7M) in Jan 2025.
- Notable investors include IPV Capital, Xiamen Hi-Tech Innovation Center, Hopesun Capital, MGI Tech, Origins Capital — 7 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for Aurefluidics Technology
- ·The full record, as it builds
Funding rounds
No funding rounds for Aurefluidics Technology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Aurefluidics Technology
Developer of microfluidic devices designed for biomedical applications. The company's platform integrates CMOS-MEMS inkjet printing chips, microfluidic design, cell printing, temperature control, and system integration, enabling researchers and healthcare professionals to advance drug development, diagnostics, and treatment through high-performance and reliable microfluidic solutions.
- Sector
- Healthcare
- HQ
- Shanghai, China
- Founded
- 2018
- Website
- aurefluidics.com/
- Ownership
- Privately Held (backing)
Aurefluidics Technology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Aurefluidics Technology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Aurefluidics Technology in its N-PORT filings yet. We sweep new filings monthly.